Dr. Reddy's Laboratories Ltd. has launched Finasteride tablets (1 mg), a bioequivalent generic version of Propecia (Finasteride) tablets in the U.S. market on January 2, 2013. The company's ANDA for Finasteride 1 mg tablets has been awarded a 180-day period of marketing exclusivity in the U.S. on January 2, 2013. The company's Finasteride tablets 1 mg is available in bottle counts of 30 and 90.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,722 INR | +1.91% |
|
+3.05% | +15.93% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.93% | 13.4B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- DRREDDY Stock
- News Dr. Reddy's Laboratories Limited
- Dr. Reddy's Laboratories Ltd. Launches Finasteride Tablets